discera.

MEDDPICC vs MEDDIC: Which Framework Actually Fits?

Jun 12, 2026·8 min·By Ahmet Ozcelik

An honest MEDDPICC vs MEDDIC comparison for B2B sales leaders — when each framework fits, what the extra letters add, and how to enforce them at scale.

MEDDPICC vs MEDDIC: Which Framework Actually Fits?

By Ahmet Ozcelik, Product Marketing Leader & GTM Engineer — Published 2026-06-12

Quick answer: MEDDPICC vs MEDDIC comes down to two added letters: MEDDPICC extends the original MEDDIC qualification framework with a Paper Process step (legal, procurement, contracting) and a second C for Competition. MEDDIC fits transactional or mid-market deals where procurement is light and competitive context is implicit; MEDDPICC fits complex enterprise deals where legal cycles stall closes and multiple vendors are in play. The bigger question for most teams isn't which framework to pick — it's how to score the fields from actual call evidence instead of trusting rep self-report in the CRM.

Most meddpicc vs meddic debates end at the acronym level, never reaching the question that determines whether either framework actually moves your forecast. The choice of letters takes two minutes. What you do with the fields after — and how reliably you score them — is what determines whether the framework runs your pipeline or just decorates your CRM.

MEDDIC vs MEDDPICC at a glance: what the acronyms actually mean

MEDDIC was created in 1996 by Dick Dunkel at Parametric Technology Corporation (PTC), working alongside Jack Napoli under SVP John McMahon. PTC became one of the most referenced examples of repeatable enterprise revenue in software history, and the methodology that drove it spread as those alumni moved to other companies.

The six-letter original breaks down as: Metrics (quantified business impact), Economic Buyer (the person with budget authority), Decision Criteria (the factors the buyer uses to evaluate vendors), Decision Process (the steps and people involved in the purchase), Identify Pain (the business problem driving urgency), Champion (the internal advocate with power and influence).

MEDDICC extends that with a second C for Competition — where the named vendors are and how the deal is positioned against them.

MEDDPICC adds P for Paper Process between Decision Process and Identify Pain, making the full acronym: Metrics, Economic Buyer, Decision Criteria, Decision Process, Paper Process, Identify Pain, Champion, Competition.

One quick definitional note: a US federal court ruled in April 2026 that MEDDPICC is a generic term and cannot be trademarked. No single organization owns it. Use it freely.

Here's the side-by-side:

FieldWhat it capturesMEDDICMEDDICCMEDDPICC
MetricsQuantified business impact of the deal
Economic BuyerWho controls the budget and signs
Decision CriteriaHow the buyer will evaluate vendors
Decision ProcessInternal steps to reach a decision
Paper ProcessLegal, procurement, security, MSA negotiation
Identify PainThe business problem creating urgency
ChampionInternal advocate with influence
CompetitionNamed competitors and bake-off status

What the extra letters in MEDDPICC actually buy you

Paper Process is the gap between "verbal yes" and "signed contract." In a mid-market deal with a straightforward MSA, that gap is days. In an enterprise deal, it can be 45 to 90 days of legal redlines, infosec questionnaires, procurement portal submissions, and three rounds of contract negotiation. If you've ever had a Q4 deal slip to Q1 because legal showed up at the last minute, Paper Process is the field that was missing from your qualification.

Some teams fold Paper Process into Decision Process — calling it D2 — and that's defensible if procurement delay is not a pattern in your ICP. But if you're selling six-figure contracts to regulated industries, financial services, or large enterprise accounts, procurement is a distinct phase with its own stakeholders and timelines. Breaking it out forces a rep to ask: "Who owns procurement on their side? What security reviews are required? Has legal seen a draft MSA?" Those questions, asked early, prevent late-stage stalls.

Competition in MEDDPICC (the second C) is rarely a mystery in real enterprise deals — it's usually one of two or three named vendors plus the "do nothing" option. The value of tracking it as a scored field is forcing a specific answer, not a vague one. "We're aware of competitors" is not a score. "They're running a parallel POC with Salesforce and have a decision meeting on the 15th" is a score.

When is the second C redundant? In transactional SMB deals where your product sells on self-service fit, the competitive context is often implicit and the rep rarely has influence over it anyway. When is it essential? Named-account enterprise selling where Microsoft, Salesforce, or an incumbent vendor is almost always in the room and the win-or-lose outcome often hinges on how strongly your Champion can make the case internally.

When to use MEDDIC vs MEDDPICC: a fit guide by motion

The wishy-washy "it depends on deal complexity" answer the rest of the internet gives you isn't useful. Here's a more concrete cut:

Use MEDDIC when:

  • ·ACVs are under ~$50K
  • ·Procurement is a credit card purchase or a simple, standard MSA
  • ·Average sales cycles are under 60 days
  • ·Competitive context is implicit and rarely changes the outcome
  • ·The rep is the primary influencer, not a committee of buyers

Use MEDDPICC when:

  • ·ACVs are over ~$100K
  • ·You're selling into named accounts with dedicated procurement teams
  • ·Security reviews, infosec questionnaires, and legal redlines regularly add 30+ days after a verbal yes
  • ·Two or more vendors are actively in a bake-off for the same budget
  • ·Your QBRs regularly feature a slide titled "Deals Stuck in Legal"

Use MEDDICC (without the P) when:

  • ·Competition is your biggest deal risk but procurement is still relatively lightweight
  • ·You're in mid-market SaaS where competitive displacement is common but contracts are clean
  • ·Your win/loss data shows you're losing more to competitors than to procurement delays

The hybrid reality most teams live in: start with MEDDIC, add the second C when your win-loss analysis against competitors starts looking bad, add the P when procurement-stalled deals start showing up in QBRs. Implementing MEDDIC with a value selling methodology cut average time-to-close by 32%, raised win rate by 143%, and grew average deal size by 48% at Patra — results that came from disciplined scoring on the original six fields before adding complexity. Nail the foundation before you extend it.

Why does rep self-report break MEDDIC and MEDDPICC scoring?

Here's the argument I don't see made clearly enough: both MEDDIC and MEDDPICC are scoring frameworks. The value comes entirely from accurate field scores. The choice of acronym is about two minutes of decision-making; the scoring method is what runs your forecast for the next two years.

And the scoring method at most companies is: rep updates a CRM field after the call. Reps are optimistic, they're busy, and they're implicitly incentivized to look forward-leaning to their managers. "Champion confirmed" gets clicked on deals where the Champion stopped returning calls three weeks ago. "Economic Buyer engaged" gets clicked on deals where the EB has never been on a call and the rep has been working a VP of IT who has no budget authority. "Metrics identified" gets clicked when the rep mentioned ROI once in passing and the prospect nodded.

The symptoms are recognizable: forecast calls where every deal is green until the rep starts explaining, slipped Q4 deals that "just needed a few more weeks," pipeline reviews where the manager asks "have you actually spoken to the EB?" and gets a pause longer than it should be.

Manager inspection via call review doesn't scale past roughly 10 reps. If you have 20 reps running 25 calls a week each, that's 500 calls. Spot-checking 5 of them isn't inspection — it's sampling, and biased sampling at that, because managers tend to review the calls they already know about. Fewer than 50% of sales leaders have high confidence in their forecasting accuracy, according to Gartner research. The framework isn't the problem. The data collection method is.

The framework gives you the right fields to score. It doesn't give you an independent source of evidence to score them against. That's the gap.

Scoring MEDDPICC from actual call evidence with programmable call analysis

If your team records on Gong, the evidence for every MEDDPICC field already exists in the transcripts. The Economic Buyer either showed up on a call or they didn't. The rep either asked a question that surfaced a quantified Metric or they didn't. The Champion either spoke with confidence about internal alignment or gave a vague non-answer. That evidence is sitting in thousands of call recordings, but Gong's native UI is not built to extract structured qualification scores across a portfolio of deals at once.

That's the specific problem programmable call analysis solves. The workflow:

Step 1 — Filter to the right calls. Connect Discera to your Gong workspace and filter to calls from the last 60 days where the linked HubSpot deal stage is Discovery, Demo, or Negotiation and the close date falls within the current quarter. This is how you segment Gong calls by deal stage to focus the analysis on deals that actually need to be in your forecast.

Step 2 — Run the MEDDPICC scoring prompt. Using Discera's Gong call analysis prompts, submit this prompt across the filtered call set:

"For each deal in this dataset, score every MEDDPICC field (Metrics, Economic Buyer, Decision Criteria, Decision Process, Paper Process, Identify Pain, Champion, Competition) on a 0–3 scale. For each score, cite the exact call quote that supports it. Flag any field scored 0 or 1 as a deal risk. Return a per-deal scorecard plus an aggregate roll-up of the three most commonly missing fields across the portfolio."

Discera runs up to 30 parallel analysis jobs — a typical quarter's worth of open-stage calls across the filtered set finishes in minutes, not hours.

Step 3 — Deliver the output before the forecast call. Set the analysis to run on a weekly schedule, pushing results to a #revops-meddpicc-audit Slack channel every Monday at 7am, plus a DOCX export for the Friday forecast review.

The output is per-deal scorecards with supporting call quotes, plus a portfolio roll-up showing which fields are systematically under-discovered across the team. That second view is the coaching signal: if Champion is scored 0 or 1 on 60% of your pipeline, that's not a deal problem — it's a process problem that shows up in every rep's calls.

The honest scope limitation: this only works when calls are recorded. Discera reads Gong — it doesn't record anything itself and never modifies Gong data. Field meetings, executive side conversations, and informal Champion-building that happens off-call are still invisible to this analysis. For those gaps, you still need rep self-report or direct manager inspection. The framework covers the full deal; the call-evidence approach covers the portion of that deal that lives in Gong recordings.

Picking a framework: a short decision checklist for sales leaders

Three questions determine which variant is right for your motion:

1. How long is your average procurement cycle after a verbal yes?

  • ·Under 15 days → MEDDIC or MEDDICC is sufficient
  • ·15–30 days → consider tracking Paper Process informally even without the P
  • ·Over 30 days → add the P; procurement is a recurring deal-killer for your ICP

2. How often do you lose to a named competitor?

  • ·Under 15% of losses → the second C may be redundant overhead
  • ·15–25% of losses → worth tracking but may not need a scored field
  • ·Over 25% of losses → add the second C; competition is a systematic risk

3. How accurate is your current forecast?

  • ·Above 80% → your scoring method is working; the acronym question is secondary
  • ·Below 80% → the framework choice is irrelevant until you fix the scoring method; no amount of extra letters helps if the fields are scored from rep optimism

Most Series B–D B2B SaaS companies selling $50K–$200K ACV deals land on MEDDPICC as the right frame. The P catches procurement stalls that would otherwise blindside Q4. The second C forces honest competitive positioning before deal review. But if you're going to add the letters, commit to scoring them from evidence — not from rep clicks in the CRM.

FAQ

Is MEDDPICC the same as MEDDICC?

No. MEDDICC adds one letter to MEDDIC — a second C for Competition. MEDDPICC adds two letters: a P for Paper Process and a second C for Competition. MEDDPICC is the more comprehensive of the two extensions. Both are now generic terms; following the April 2026 federal court ruling, no organization holds a trademark on either.

Which is harder to implement, MEDDIC or MEDDPICC?

Neither is technically hard to implement — both are just structured qualification fields. MEDDPICC introduces two additional fields that require clear definitions (what counts as a Paper Process step? who owns it on the buyer's side?) and that's where most rollouts stumble. The real implementation challenge, for both, is consistent scoring. A MEDDPICC framework scored by rep intuition into a CRM field gives you worse data than a MEDDIC framework scored from actual call evidence. The number of letters matters less than the rigor of the scoring method.

How is MEDDIC different from Challenger Sale?

MEDDIC is a qualification framework — it tells you whether a deal is real, who the buyer is, and whether you have the relationships and process coverage to close it. The Challenger Sale is a selling methodology that prescribes how a rep should interact with a buyer: teach, tailor, and take control of the conversation. They operate at different levels of the sales motion and are not competing frameworks. Many enterprise sales teams run Challenger as their interaction model and MEDDPICC as their qualification model simultaneously. MEDDIC vs Sandler and SPIN vs MEDDIC are similar non-competitions: one framework addresses buyer interaction, the other addresses deal qualification.

Do you need MEDDPICC certification to roll it out at your company?

No. Following the April 2026 federal court ruling that MEDDPICC is a generic term not subject to trademark, no single organization owns it. You can train your team on the methodology, create internal scorecards, and customize field definitions without any certification, licensing, or vendor relationship. There are paid training programs available if you want external facilitation, but they're optional, not required.

Can MEDDPICC be used for customer success and renewals?

Yes, and it's underused in that context. Champion and Economic Buyer are directly applicable to renewal risk: if neither has been active in your last three QBRs, that's a churn signal you should be surfacing before the renewal conversation. Paper Process matters when a renewal involves renegotiating an MSA, adding new product lines, or passing a security re-review. Metrics becomes the ROI case that justifies the renewal budget internally. Teams running MEDDPICC for expansion and renewal motions often find that the framework surfaces at-risk accounts earlier than lagging indicators like NPS or product usage alone — because a Champion going quiet on calls is a leading indicator, not a lagging one. Gong records customer success calls too, which means the same call-evidence scoring workflow applies. The methodology for retrospective analysis — looking back at closed-won and closed-lost deals to calibrate which fields actually predicted outcomes — is covered in detail in our guide to win/loss analysis on Gong calls.

If your team runs on Gong and you want to see what your MEDDPICC scores actually look like from call evidence — not from CRM fields — Start a free trial at discera.ai and run the scoring prompt across your current quarter's open pipeline.

§ Author

Ahmet Ozcelik

Founder of Discera. Building programmable call analysis for revenue teams.

More posts · All Discera writing →

§ Run it on your own calls

Run the analysis from this post on your own calls.

You’ve read the playbook. The 100-call free trial is enough to actually run it.

No credit card · After your trial, your workspace continues on the Free plan

§ Common questions

Frequently asked.

Is MEDDPICC the same as MEDDICC?

No. MEDDICC adds one letter to MEDDIC — a second C for Competition. MEDDPICC adds two letters: a P for Paper Process and a second C for Competition. MEDDPICC is the longer of the two extensions.

Which is harder to implement, MEDDIC or MEDDPICC?

MEDDPICC is harder to implement only because it has two additional fields to define, train on, and score. The real implementation challenge with both is consistent, evidence-backed scoring — not the number of fields.

How is MEDDIC different from Challenger Sale?

MEDDIC is a qualification framework that tells you whether a deal is real and closable. The Challenger Sale is a selling methodology that prescribes how a rep should interact with a buyer — teaching, tailoring, taking control. They operate at different levels and can be used together.

Do you need MEDDPICC certification to roll it out at your company?

No. Following the April 2026 federal court ruling that MEDDPICC is a generic term not subject to trademark, no single organization owns it. You can adopt and train on the framework without any certification or licensing requirement.

Can MEDDPICC be used for customer success and renewals?

Yes, and it's underused there. Champion and Economic Buyer are directly applicable to renewal risk — if neither has been active in your last three QBRs, that's a churn signal. Paper Process matters when a renewal involves a renegotiated MSA or security re-review. Metrics becomes the ROI case that justifies the renewal budget.